Prediction of the mechanism for the combination of diallyl trisulfide and cisplatin against gastric cancer: a network pharmacology study and pharmacological evaluation.

Front Pharmacol · 2023 · PMC10642245 · PMID 37964870

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, the levels of XBP1 and Calnexin showed a trend similar to that of IRE1α ( Figures 6B, E ). 3.7 DATS combined with DDP synergistically inhibited SGC-7901 tumor growth in vivo An SGC-7901 subcutaneous xenograft model in nude mice was established to further evaluate the in vivo effects of combined exposure.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.